LATS1 and cervical cancer: This study included participants diagnosed with advanced cervical cancer at stages IIIB and IVA, with a focus on analyzing the levels of LATS1 and NF-κB and their association with radiation therapy outcomes, as assessed according to the RECIST 1.1 criteria [24].